Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer

Geographic Proximity Not a Factor in CMO Selection

Annual outsourcing study y identifies the markets best poised to profit from the internationalization of the outsourcing.
Sep 29, 2014

Annual outsourcing study identifies the markets best poised to profit from the internationalization of the outsourcing.

Targeting Different Off-Shore Destinations

Annual study shows geographic proximity not a factor in CMO selection.
Sep 2, 2014

Annual study shows geographic proximity not a factor in CMO selection.

Study CMO Technical Expertise is Not Enough

Sep 1, 2014

Sponsors are demanding high levels of professionalism, performance, and effectiveness in managerial areas to accompany CMOs?' technical expertise.

Relationship-building at Top of Mind for Clients

Annual study shows CMO technical expertise is not enough.
Aug 2, 2014

Annual study shows CMO technical expertise is not enough.

Cost Is No Longer the Driving Force for Outsourcing

With budgets growing, clients see CMOs' costs as less crucial and consider other factors.
Jun 29, 2014

With budgets growing, clients see CMOs' costs as less crucial and consider other factors.

Outsourcing No Longer Just for Cost-Cutting

With budgets growing, clients see CMOs' costs as less crucial.
Jun 2, 2014

With budgets growing, clients see CMOs' costs as less crucial.

Outsourcing Remains Strong In Traditional Areas

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
May 2, 2014

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

Biopharma Outsourcing Activities Update

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
Apr 2, 2014

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

Top 10 Outsourcing Trends in Biopharmaceutical Manufacturing

The author highlights the top 10 outsourcing trends revealed during a survey of biopharmaceutical manufacturers.
Feb 28, 2014

In biopharmaceutical manufacturing, outsourcing and off-shoring have migrated into much more high-value areas.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here